Cardiac Resynchronization Therapy in Heart Failure
Cardiac resynchronization therapy (CRT) is a device-based treatment for patients with advanced heart failure and ventricular dyssynchrony. It improves heart efficiency, symptoms, and survival.
Key Highlights:
- Indications: Patients with reduced ejection fraction, widened QRS complex, and persistent symptoms despite optimal medical therapy.
- Mechanism: CRT coordinates contraction of the left and right ventricles to improve cardiac output.
- Clinical benefits: Reduces hospitalization, improves exercise tolerance, and enhances quality of life.
- Device monitoring: Remote follow-up ensures optimal pacing and detects complications early.
- Future developments: Integration with AI allows predictive modeling for therapy response.
CRT remains a cornerstone therapy for select heart failure patients, combining mechanical support with advanced monitoring technologies.
Related Conference of Cardiac Resynchronization Therapy in Heart Failure
August 27-28, 2026
17th International Conference on Exhibition on Lasers, Optics & Photonics
Zurich, Switzerland
August 27-28, 2026
11th International Conference on Quantum Physics and Mechanics
Zurich, Switzerland
October 12-13, 2026
9th International Conference on Astronomy, Astrophysics and Space Science
Paris, France
October 26-27, 2026
6th International Conference on Applied Physics and Materials Science
Amsterdam, Netherlands

